Intra-arterial administration of epirubicin in the treatment of Nonresectable hepatocellular carcinoma Epirubicin Study Group for Hepatocellular Carcinoma Original Articles Pages: 183 - 189
Phase I study of beta-alanyl-melphalan as a potent anticancer drug Bao-Ling TsayLloyd Wolfinbarger Jr. Original Articles Pages: 190 - 196
In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin Hidenobu TakahashiYasutsuna SasakiWeon-Seon Hong Original Articles Pages: 197 - 200
Comparative metabolism and elimination of adriamycin and 4′-epiadriamycin in the rat Trevor W. SweatmanMervyn Israel Original Articles Pages: 201 - 206
Relative cardiotoxicity and cytotoxicity of anthraquinonyl glucosaminosides Jon W. BanningHanley N. AbramsonThomas H. Corbett Original Articles Pages: 207 - 212
Effects of chronic administration of doxorubicin on plasma levels of prostaglandins, thromboxane B2, and fatty acids in rats Timothy W. RobisonShri N. Giri Original Articles Pages: 213 - 220
Activity and distribution studies of etoposide and mitozolomide in vivo and in vitro against human choriocarcinoma cell lines Charles J. BrindleyR. Barbara PedleyEdward S. Newlands Original Articles Pages: 221 - 225
Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis Kapil BhallaSteven Grant Original Articles Pages: 226 - 232
Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay Toshiaki SaitoMichael E. BerensCharles E. Welander Original Articles Pages: 233 - 239
Hepatic extraction, metabolism and biliary excretion of doxorubicin in the isolated prefused rat liver Francois BalletPatricia VrignaudRaoul Poupon Original Articles Pages: 240 - 245
In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy S. N. WolffW. W. GroshK. R. Hande Original Articles Pages: 246 - 249
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies Bayard L. PowellHyman B. MussCharles L. Spurr Original Articles Pages: 250 - 252
Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy Brian L. SamuelsNicholas J. VogelzangB. J. Kennedy Original Articles Pages: 253 - 256
Changes in serum iron levels following very high-dose cisplatin C. F. PolleraF. AmeglioC. Parracino Original Articles Pages: 257 - 260
Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia Joseph D. BorsiThomas ReveszDezso Schuler Original Articles Pages: 261 - 264
A phase II trial of diaziquone in patients with head and neck cancer Francisco MuñizEnrique Vélez-GarcíaMark Becker Original Articles Pages: 265 - 268
5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules W. K. LamS. Y. SoMary Ip Original Articles Pages: 269 - 271